Personal profile
Area of Expertise
Dr. O'Bryant is the Executive Director of the Institute for Translational Research and Dr. Joe and Peggy Schooler Endowed Chair in Pharmacology and Neuroscience. He is one of the world's leading experts in blood-based biomarkers and a global leader in cognitive aging and brain health among communities. He leads multiple initiatives for the generation of precision medicine models for a range of neurodegenerative diseases, including Alzheimer's Disease, Parkinson's disease, Lewy Body Dementia, and Down Syndrome.
Education/Academic qualification
BS in Psychology, Louisiana State University
MA in Clinical Psychology, University at Albany
PhD in Clinical Psychology, University at Albany
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Yr4- I3C DECADE: Disparities a
O'Bryant, S. (PI) & Zhang, F. (CoI)
1/07/25 → 30/06/26
Project: Research
-
The impact of bilingualism on
O'Bryant, S. (PI) & Petersen, M. (CoI)
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
1/05/23 → 31/03/28
Project: Research
-
Health & Aging Brain Study - H
O'Bryant, S. (PI)
NIA: National Institute on Aging
1/09/22 → 31/08/27
Project: Research
-
Health & Aging Brain Study - H
O'Bryant, S. (PI) & Petersen, M. (CoI)
NIA: National Institute on Aging
1/09/22 → 31/08/27
Project: Research
-
Health & Aging Brain Study - H
O'Bryant, S. (PI), Johnson, L. (CoI) & Barber, R. (CoI)
NIA: National Institute on Aging
1/09/22 → 31/08/27
Project: Research
-
Guidelines for the standardization of pre-analytic variables for blood-based biomarker studies in Alzheimer’s disease research
O'Bryant, S., Gupta, V. B., Henriksen, K., Edwards, M., Jeromin, A., Lista, S., Bazenet, C., Soares, H., Lovestone, S., Hampel, H., Montine, T. J., Blennowe, K., Foroud, T. M., Carrillo, M., Graff-Radford, N. R., Laske, C., Breteler, M., Shaw, L. M., Trojanowski, J. Q. & Schupf, N. & 8 others, , 2015, In: Alzheimer's and Dementia.Research output: Contribution to journal › Article › peer-review
-
Fatty Acid-Binding Protein 3 Is a Marker of Neurodegeneration and White Matter Hyperintensity Burden in Mexican American Older Adults
Health and Aging Brain Study – Health Disparities (HABS-HD) Study Team, 25 Oct 2022, In: Journal of Alzheimer's Disease. 90, 1, p. 61-68 8 p.Research output: Contribution to journal › Article › peer-review
-
Levels of a-2 Macroglobulin in cognitively normal Mexican-Americans with Subjective Cognitive Decline
Hall, J., Wiechmann, A., Johnson, L., Edwards, M. & O'Bryant, S., 2019, In: Current Neurobiology. p. 22-25 4 p.Research output: Contribution to journal › Article › peer-review
-
Total testosterone and neuropsychiatric symptoms in elderly men with Alzheimer's disease
Texas Alzheimer's Research Care Consortium & Edwards, M., 1 Dec 2015, In: Alzheimer's Research and Therapy. 7, 1, 107.Research output: Contribution to journal › Article › peer-review
-
Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease
ARUK Consortium, GERAD/PERADES, CHARGE, ADGC, EADI, International Genomics of Alzheimer's Project (IGAP), ARUK Consortium & GERAD/PERADES, CHARGE, ADGC, EADI, 1 Jan 2018, In: Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring. 10, p. 595-598 4 p.Research output: Contribution to journal › Article › peer-review